Biomerica Appoints Gary Huff, Former LabCorp CEO, To Board Of Directors To Drive Growth And Innovation In Diagnostics

Biomerica Inc., a global provider of advanced diagnostic solutions, has announced the appointment of Gary Huff as an independent member of its Board of Directors. Mr. Huff brings extensive leadership experience in the diagnostics and healthcare services industries, including his previous role as Chief Executive Officer of LabCorp Diagnostics, one of the world’s largest clinical laboratory networks.

With a career spanning several decades, Mr. Huff has established himself as a results-driven and growth-oriented leader. He has successfully managed commercial laboratories of various sizes from small private enterprises to large public corporations achieving consistent profitability, operational excellence, and organizational transformation. His leadership has been instrumental in driving strategic growth and delivering strong financial performance across multiple sectors of the diagnostics industry.

Zack Irani-Cohen, Chief Executive Officer of Biomerica, stated, “Gary’s exceptional track record of building successful diagnostics businesses, forging strategic partnerships, and delivering shareholder value will be invaluable as Biomerica continues to advance its innovative diagnostic portfolio. We are excited to welcome him to our Board and look forward to his insights as we expand our market presence and pursue our mission of improving patient care and access to our innovative products.”

Mr. Huff, said in a statement, “I am honored to join Biomerica’s Board of Directors at such an exciting time in the company’s growth. Biomerica’s innovative pipeline, particularly the inFoods® IBS product, has the potential to transform how patients and physicians manage the widespread condition of irritable bowel syndrome. I look forward to contributing to the Company’s strategic initiatives and working with the leadership team to drive sustainable growth and improved patient outcomes.”

Mr. Huff’s appointment adds significant strategic depth to Biomerica’s Board. His experience and vision are expected to support the company’s mission of expanding access to innovative diagnostic solutions worldwide. In addition to his new role at Biomerica, Mr. Huff currently leads his own advisory firm and serves on the boards of Lighthouse Labs and Tribal Diagnostics. He has also provided strategic consulting services to major healthcare systems and global firms, including McKinsey & Company and Cerberus Capital Management.